HP Helmerich & Payne, Inc. Insider Trading

Hair Cara M. (SVP) sold 28,345 shares of HP at $41.45 on 2026-05-18, reducing holdings by 28.3K shares to 147.2K; stock near 52-week highs.

Hair Cara M., SVP of Corporate Services & Chief Legal Officer, executed an open-market sale of 28,345 shares at $41.45 on 2026-05-18, reducing her holdings from 175.6K to 147.2K shares (a 16.1% reduction). The transaction occurred near the stock's 52-week high of $41.78, with the current price at $40.94 representing a -2.0% pullback from that peak. Her prior sell at this ticker on 2026-03-19 resulted in a 90-day return of +13.4%, meaning the stock rose after that sale, and her cross-ticker track record shows 0 of 1 prior sells were well-timed at the 90-day mark. The company reported a net loss of $-58.6M over its most recent full fiscal year despite revenue growth of +35.9%, a fundamental inconsistency that may warrant investor attention alongside executive share reductions.

SVP/CLO Hair Cara M. sold 58,771 shares (58.8K) of HP at $36.62, reducing stake 25.1% to 175,589 shares.

Hair Cara M., SVP Corporate Services and Chief Legal Officer, executed a substantial sale of 58,771 shares (58.8K) at $36.62 on 2026-03-19, worth $2,152,194.02 ($2.2M), reducing her holdings by 25.1% from 234,360 to 175,589 shares. The sale occurred near the 52-week high of $37.13, with the stock trading at exactly the year-to-date peak, though the company's fundamentals remain challenged: Helmerich & Payne reported a net loss of $-96,706,000.00 over its most recent full fiscal year despite strong revenue growth of +35.9% year-over-year. The timing and magnitude of the sale—reducing a senior executive's stake by one-quarter while the stock sits at its yearly maximum—warrant investor attention, particularly given the company's unprofitability and the elevated size of the transaction for an officer of this standing.

HP Director Helmerich sells 75,000 shares ($2.1M) at $28.12; stock down 23% from 52-week high, company unprofitable

Director Hans Helmerich executed 2 separate sales totaling 75,000 shares for $2,109,000.00 on 2025-12-19, reducing his holdings by 5.8% to 1,215,915 shares. The timing merits attention: his prior 2 sells at HP in September 2023 both showed negative 90-day returns (-14.2% and -13.8%), establishing a pattern of well-timed exits. The current stock sits 23.0% below its 52-week high and the company reported negative net income ($-162,758,000.00) for its most recent full fiscal year despite 35.9% annual revenue growth, signaling an earnings quality issue. While the stock has rebounded 5.7% over 30 days, the director's historical track record at this ticker suggests his sales preceded material declines, and Helmerich & Payne's ongoing unprofitability may warrant scrutiny as a contextual backdrop to this disposal.

Director Randy A Foutch purchased 3,800 shares of HP at $26.25 on 2025-02-18; cluster pattern with 2 other insider buys in 14 days amid -41.4% 52-week decline.

Foutch purchased 3,800 shares (3.8K shares) for $99,750.00, increasing his holdings by 14.2% to 30,624 shares. This buy occurs within a broader cluster pattern: 2 other insiders also purchased within the past 14 days, suggesting coordinated accumulation despite a difficult price environment. The stock has declined -41.4% from its 52-week high of $43.89 and is down -29.3% over 30 days, indicating the buy coincides with sharp weakness. Helmerich & Payne's fundamentals remain intact with P/E of 8.40 and net income of $54.8M, though annual revenue growth is -4.0%, presenting a backdrop of valuation compression alongside operational headwinds.

Director Chariag Belgacem purchased 37,356 shares of HP at $27.08; holdings increase 216.6% to 54.6K shares

Chariag Belgacem, a Director at Helmerich & Payne, purchased 37,356 shares at $27.08 on 2025-02-10, tripling his position from 17,250 to 54,606 shares. The transaction occurred when HP shares trade at $27.24 current price, down 37.9% from the 52-week high of $43.89 and down 20.5% over the prior 30 days. The company operates at a lean 8.90 P/E ratio with positive net income of $54.8M against revenue of $677.3M, though annual revenue contracted by 4.0% year-over-year, signaling headwinds in the business. This substantial accumulation by a director at a depressed valuation relative to recent trading history—and while the business faces revenue pressure—represents a material stake increase that merits examination of the director's underlying rationale and broader insider behavior patterns at the company.

HP CEO Lindsay buys 20,000 shares at $27.55 amid 37.9% decline from 52-week high

CEO John W. Lindsay purchased 20,000 shares at $27.55 on 2025-02-10, increasing his holdings to 691,214 shares. The transaction occurs as HP trades at $27.24, down 37.9% from the 52-week high of $43.89 and down 20.5% over the last 30 days. The company's latest quarter generated $677.3M in revenue and $54.8M in net income, though annual revenue growth was -4.0% year-over-year. With a P/E of 8.90 and market cap of $2.7B, the stock is trading at a compressed valuation relative to recent price levels. The purchase represents a material commitment by the company's top executive during a period of significant price pressure.

HP CFO Vann J Kevin bought 3,300 shares at $30.19 on 2024-09-27; stock now -29.2% from 52-week high

Senior VP and CFO Vann J Kevin purchased 3,300 shares at $30.19, establishing an initial open-market position in Helmerich & Payne. The transaction occurred when HP traded near the lower-middle band of its 52-week range ($29.65–$44.61) and has since declined a further 3.2% over 30 days and 12.4% over 90 days, leaving the stock 29.2% below its 52-week high. Kevin's cross-ticker track record shows 1 prior buy with an average 90-day return of -2.2% and a 0.00% win rate, providing no evidence of timing acuity. While HP's fundamentals remain solid—revenue growth of +39.5%, P/E of 9.00, and net income of $88.7M on $697.7M revenue—the subsequent price weakness and the CFO's limited prior success in open-market equity purchases suggest investors should monitor whether additional insider activity materializes before drawing confidence from this single transaction.